AMBASSADOR OF TOPX NETWORK
AMBASSADOR OF TOPX NETWORK
Chris De Jonghe | Valorization Director, Oncode Institute
Chris De Jonghe | Valorization Director, Oncode Institute
A biochemist by training, Chris De Jonghe is currently valorization director at Oncode Institute. Previously, she managed a 200 M€ evergreen Life Sciences VC fund at investment company PMV in Belgium. De Jonghe also worked for more than 10 years in the tech transfer team of the Flanders Institute for Biotechnology (VIB), where she was involved in research collaborations, IP licensing and new venture creation. Chris obtained her PhD in the field of neurodegeneration and holds a law degree as well. She served on the boards of several operational life sciences companies, investment funds and cluster organizations.
About Oncode Institute
Oncode Institute unites more than 800 excellent fundamental cancer researchers in the Neth-erlands. Our mission is to stimulate innovations in the diagnosis and treatment of cancer. The ultimate goal is to help patients survive, improve the quality of life for those affected and con-tribute to a more affordable healthcare system. Oncode Institute translates fundamental in-sights into the biology of cancer into new diagnostics, new drugs and innovative treatments. Oncode's three strategic pillars to improve patient outcomes are Excellent Science, Collaboration and Valorization. Oncode is funded by KWF, together with the Ministries of Economic Affairs & Climate, Education Culture & Science and Health, Welfare & Sport, and Health~Holland, with a total amount of €120 million until 2022.
Oncode Institute unites more than 800 excellent fundamental cancer researchers in the Neth-erlands. Our mission is to stimulate innovations in the diagnosis and treatment of cancer. The ultimate goal is to help patients survive, improve the quality of life for those affected and con-tribute to a more affordable healthcare system. Oncode Institute translates fundamental in-sights into the biology of cancer into new diagnostics, new drugs and innovative treatments. Oncode's three strategic pillars to improve patient outcomes are Excellent Science, Collaboration and Valorization. Oncode is funded by KWF, together with the Ministries of Economic Affairs & Climate, Education Culture & Science and Health, Welfare & Sport, and Health~Holland, with a total amount of €120 million until 2022.
| Powered by: Hyphen Projects BV | Connect with us | Join TOPX | |||
| Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 | | |
© Copyright 2020 by Hyphen Projects